FDA inspection
Spectrum Distribution & Marketing Inc.: FDA inspection ending Nov 17, 1999
FDA inspection 4829 · Beverly Hills, CA
Key facts
| Inspection ID | 4829 |
|---|---|
| Firm | Spectrum Distribution & Marketing Inc. |
| FEI number | 3000210330 |
| Address | 226 S Beverly Dr Ste 200 |
| City | Beverly Hills |
| State | CA |
| ZIP | 90212-3844 |
| Fiscal year | 2000 |
| Inspection end date | Nov 17, 1999 |
| Project area | Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data